Arthur J Klausner's most recent trade in Monopar Therapeutics Inc was a trade of 11,365 Stock Options done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 11,365 | 11,365 | - | - | Stock Options | |
| Monopar Therapeutics Inc | Klausner J. Arthur | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 2,533 | 0 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Klausner Arthur J. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 2,533 | 30,863 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 2,534 | 25,797 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 2,534 | 5,066 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 2,533 | 23,263 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 2,533 | 7,600 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 13,930 | 13,930 | - | - | Stock Options | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 10,133 | 10,133 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 2,859 | 0 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 2,859 | 20,730 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2022 | 2,859 | 17,871 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2022 | 2,859 | 2,859 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2022 | 2,859 | 15,012 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2022 | 2,859 | 5,718 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2022 | 2,859 | 8,577 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2022 | 2,859 | 12,153 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2021 | 752 | 7,792 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2021 | 752 | 1,502 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2021 | 751 | 7,040 (0%) | 0% | - | Common Stock | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2021 | 751 | 2,254 | - | - | Restricted Stock Units | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 4,443 | 4,443 | - | - | Stock Options | |
| Monopar Therapeutics Inc | Arthur J. Klausner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 3,005 | 3,005 | - | - | Restricted Stock Units |